132 related articles for article (PubMed ID: 1416908)
1. An ELISA system for evaluating antiretroviral activity against Rauscher murine leukemia virus.
Hollingshead MG; Westbrook L; Ross MJ; Bailey J; Qualls KJ; Allen LB
Antiviral Res; 1992 Jun; 18(3-4):267-74. PubMed ID: 1416908
[TBL] [Abstract][Full Text] [Related]
2. Optimization of the reverse transcriptase assay for the detection of viral burden in mice infected with Rauscher murine leukemia virus.
White EL; Westbrook L; Hollingshead MG; Shannon WM
J Virol Methods; 1996 Oct; 62(1):63-70. PubMed ID: 8910649
[TBL] [Abstract][Full Text] [Related]
3. Suppression of retroviral propagation and disease by suramin in murine systems.
Ruprecht RM; Rossoni LD; Haseltine WA; Broder S
Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7733-7. PubMed ID: 2415971
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo.
Shannon WM
Ann N Y Acad Sci; 1977 Mar; 284():472-507. PubMed ID: 280146
[TBL] [Abstract][Full Text] [Related]
5. Characterization of molecular species carrying gross cell surface antigen.
Snyder HW; Stockert E; Fleissner E
J Virol; 1977 Aug; 23(2):302-14. PubMed ID: 69725
[TBL] [Abstract][Full Text] [Related]
6. Castanospermine vs. its 6-O-butanoyl analog: a comparison of toxicity and antiviral activity in vitro and in vivo.
Ruprecht RM; Bernard LD; Bronson R; Gama Sosa MA; Mullaney S
J Acquir Immune Defic Syndr (1988); 1991; 4(1):48-55. PubMed ID: 1984055
[TBL] [Abstract][Full Text] [Related]
7. Development of an enzyme-linked immunosorbent assay based on the murine leukemia virus p30 capsid protein.
Wu DT; Aiyer S; Villanueva RA; Roth MJ
J Virol Methods; 2013 Nov; 193(2):332-6. PubMed ID: 23810854
[TBL] [Abstract][Full Text] [Related]
8. Recombinants between temperature-sensitive mutants of rauscher murine leukemia virus and BALB:virus-2: genetic mapping of the Rauscher murine leukemia virus genome.
Merregaert J; Barbacid M; Aaronson SA
J Virol; 1981 Jul; 39(1):219-28. PubMed ID: 6268812
[TBL] [Abstract][Full Text] [Related]
9. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens.
Schwendener RA; Gowland P; Horber DH; Zahner R; Schertler A; Schott H
Antiviral Res; 1994 May; 24(1):79-93. PubMed ID: 7944315
[TBL] [Abstract][Full Text] [Related]
10. Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors.
Chen W; Qin H; Chesebro B; Cheever MA
J Virol; 1996 Nov; 70(11):7773-82. PubMed ID: 8892898
[TBL] [Abstract][Full Text] [Related]
11. Use of an enzyme-linked immunosorbent assay performed directly on fixed infected cell monolayers for evaluating drugs against varicella-zoster virus.
Berkowitz FE; Levin MJ
Antimicrob Agents Chemother; 1985 Aug; 28(2):207-10. PubMed ID: 3010838
[TBL] [Abstract][Full Text] [Related]
12. A rapid bioassay to monitor murine leukemia virus infection in mice using cellular gp 71 binding.
Reed CD; Fowler AK
J Virol Methods; 1982 May; 4(4-5):209-17. PubMed ID: 6286701
[TBL] [Abstract][Full Text] [Related]
13. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
[TBL] [Abstract][Full Text] [Related]
14. The effect of murine interferon-alpha/beta on an established Rauscher murine leukemia virus-induced erythroleukemia in BALB/c mice.
Hekman RA; Trapman J
Int J Cancer; 1985 Apr; 35(4):515-20. PubMed ID: 2580803
[TBL] [Abstract][Full Text] [Related]
15. Phylogenetic relationship of the complete Rauscher murine leukemia virus genome with other murine leukemia virus genomes.
Khimani AH; Lim M; Graf TG; Smith TF; Ruprecht RM
Virology; 1997 Nov; 238(1):64-7. PubMed ID: 9375009
[TBL] [Abstract][Full Text] [Related]
16. Optimization of in situ cellular ELISA performed on influenza A virus-infected monolayers for screening of antiviral agents.
Myc A; Anderson MJ; Baker JR
J Virol Methods; 1999 Feb; 77(2):165-77. PubMed ID: 10092140
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
Schenk PJ; Howe ML
J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
[TBL] [Abstract][Full Text] [Related]
18. Measurement of Gross cell-surface antigen and p30 level in murine retrovirus-infected cell lines.
Gerlier D; Gisselbrecht S; Guillemain B; Doré JF
Br J Cancer; 1981 May; 43(5):659-68. PubMed ID: 7248150
[TBL] [Abstract][Full Text] [Related]
19. The effect of high doses of poly(I).poly(C) induced mouse L cell interferon on Rauscher leukemia virus induced erythroleukemia in BALB/c mice.
Hekman RA; Prins ME; Bosveld IJ; Trapman J
Int J Cancer; 1981; 27(4):493-500. PubMed ID: 6168593
[TBL] [Abstract][Full Text] [Related]
20. In vivo analysis of castanospermine, a candidate antiretroviral agent.
Ruprecht RM; Mullaney S; Andersen J; Bronson R
J Acquir Immune Defic Syndr (1988); 1989; 2(2):149-57. PubMed ID: 2495348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
